Global Ligases Enzymes Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
- 1.1 Ligases Enzymes Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Ligases Enzymes Market Size Growth Rate by Product
- 1.4.2 E. coli DNA ligase
- 1.4.3 T4 DNA ligase
- 1.4.4 Mammalian ligases
- 1.4.5 Thermostable ligases
- 1.5 Market by End User
- 1.5.1 Global Ligases Enzymes Market Size Growth Rate by End User
- 1.5.2 Academic & Research Institutes
- 1.5.3 Hospitals & Diagnostic Centers
- 1.5.4 Pharmaceutical & Biotechnology Companies
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Ligases Enzymes Market Size
- 2.1.1 Global Ligases Enzymes Revenue 2014-2025
- 2.1.2 Global Ligases Enzymes Sales 2014-2025
- 2.2 Ligases Enzymes Growth Rate by Regions
- 2.2.1 Global Ligases Enzymes Sales by Regions
- 2.2.2 Global Ligases Enzymes Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Ligases Enzymes Sales by Manufacturers
- 3.1.1 Ligases Enzymes Sales by Manufacturers
- 3.1.2 Ligases Enzymes Sales Market Share by Manufacturers
- 3.1.3 Global Ligases Enzymes Market Concentration Ratio (CR5 and HHI)
- 3.2 Ligases Enzymes Revenue by Manufacturers
- 3.2.1 Ligases Enzymes Revenue by Manufacturers (2014-2019)
- 3.2.2 Ligases Enzymes Revenue Share by Manufacturers (2014-2019)
- 3.3 Ligases Enzymes Price by Manufacturers
- 3.4 Ligases Enzymes Manufacturing Base Distribution, Product Types
- 3.4.1 Ligases Enzymes Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Ligases Enzymes Product Type
- 3.4.3 Date of International Manufacturers Enter into Ligases Enzymes Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Ligases Enzymes Sales by Product
- 4.2 Global Ligases Enzymes Revenue by Product
- 4.3 Ligases Enzymes Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Ligases Enzymes Breakdown Data by End User
6 North America
- 6.1 North America Ligases Enzymes by Countries
- 6.1.1 North America Ligases Enzymes Sales by Countries
- 6.1.2 North America Ligases Enzymes Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Ligases Enzymes by Product
- 6.3 North America Ligases Enzymes by End User
7 Europe
- 7.1 Europe Ligases Enzymes by Countries
- 7.1.1 Europe Ligases Enzymes Sales by Countries
- 7.1.2 Europe Ligases Enzymes Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Ligases Enzymes by Product
- 7.3 Europe Ligases Enzymes by End User
8 Asia Pacific
- 8.1 Asia Pacific Ligases Enzymes by Countries
- 8.1.1 Asia Pacific Ligases Enzymes Sales by Countries
- 8.1.2 Asia Pacific Ligases Enzymes Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Ligases Enzymes by Product
- 8.3 Asia Pacific Ligases Enzymes by End User
9 Central & South America
- 9.1 Central & South America Ligases Enzymes by Countries
- 9.1.1 Central & South America Ligases Enzymes Sales by Countries
- 9.1.2 Central & South America Ligases Enzymes Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Ligases Enzymes by Product
- 9.3 Central & South America Ligases Enzymes by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Ligases Enzymes by Countries
- 10.1.1 Middle East and Africa Ligases Enzymes Sales by Countries
- 10.1.2 Middle East and Africa Ligases Enzymes Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Ligases Enzymes by Product
- 10.3 Middle East and Africa Ligases Enzymes by End User
11 Company Profiles
- 11.1 Thermo Fisher Scientific
- 11.1.1 Thermo Fisher Scientific Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Thermo Fisher Scientific Ligases Enzymes Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Thermo Fisher Scientific Ligases Enzymes Products Offered
- 11.1.5 Thermo Fisher Scientific Recent Development
- 11.2 Merck
- 11.2.1 Merck Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Merck Ligases Enzymes Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Merck Ligases Enzymes Products Offered
- 11.2.5 Merck Recent Development
- 11.3 New England Biolabs
- 11.3.1 New England Biolabs Company Details
- 11.3.2 Company Business Overview
- 11.3.3 New England Biolabs Ligases Enzymes Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 New England Biolabs Ligases Enzymes Products Offered
- 11.3.5 New England Biolabs Recent Development
- 11.4 Promega
- 11.4.1 Promega Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Promega Ligases Enzymes Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Promega Ligases Enzymes Products Offered
- 11.4.5 Promega Recent Development
- 11.5 Illumina
- 11.5.1 Illumina Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Illumina Ligases Enzymes Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Illumina Ligases Enzymes Products Offered
- 11.5.5 Illumina Recent Development
- 11.6 Agilent Technologies
- 11.6.1 Agilent Technologies Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Agilent Technologies Ligases Enzymes Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Agilent Technologies Ligases Enzymes Products Offered
- 11.6.5 Agilent Technologies Recent Development
- 11.7 F. Hoffmann-la Roche
- 11.7.1 F. Hoffmann-la Roche Company Details
- 11.7.2 Company Business Overview
- 11.7.3 F. Hoffmann-la Roche Ligases Enzymes Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 F. Hoffmann-la Roche Ligases Enzymes Products Offered
- 11.7.5 F. Hoffmann-la Roche Recent Development
- 11.8 Takara Bio
- 11.8.1 Takara Bio Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Takara Bio Ligases Enzymes Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Takara Bio Ligases Enzymes Products Offered
- 11.8.5 Takara Bio Recent Development
- 11.9 QIAGEN N.V.
- 11.9.1 QIAGEN N.V. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 QIAGEN N.V. Ligases Enzymes Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 QIAGEN N.V. Ligases Enzymes Products Offered
- 11.9.5 QIAGEN N.V. Recent Development
- 11.10 Becton, Dickinson
- 11.10.1 Becton, Dickinson Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Becton, Dickinson Ligases Enzymes Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Becton, Dickinson Ligases Enzymes Products Offered
- 11.10.5 Becton, Dickinson Recent Development
12 Future Forecast
- 12.1 Ligases Enzymes Market Forecast by Regions
- 12.1.1 Global Ligases Enzymes Sales Forecast by Regions 2019-2025
- 12.1.2 Global Ligases Enzymes Revenue Forecast by Regions 2019-2025
- 12.2 Ligases Enzymes Market Forecast by Product
- 12.2.1 Global Ligases Enzymes Sales Forecast by Product 2019-2025
- 12.2.2 Global Ligases Enzymes Revenue Forecast by Product 2019-2025
- 12.3 Ligases Enzymes Market Forecast by End User
- 12.4 North America Ligases Enzymes Forecast
- 12.5 Europe Ligases Enzymes Forecast
- 12.6 Asia Pacific Ligases Enzymes Forecast
- 12.7 Central & South America Ligases Enzymes Forecast
- 12.8 Middle East and Africa Ligases Enzymes Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Ligases Enzymes Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
The global Ligases Enzymes market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Ligases Enzymes market based on company, product type, end user and key regions.
This report studies the global market size of Ligases Enzymes in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ligases Enzymes in these regions.
This research report categorizes the global Ligases Enzymes market by top players/brands, region, type and end user. This report also studies the global Ligases Enzymes market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Thermo Fisher Scientific
Merck
New England Biolabs
Promega
Illumina
Agilent Technologies
F. Hoffmann-la Roche
Takara Bio
QIAGEN N.V.
Becton, Dickinson
Market size by Product
E. coli DNA ligase
T4 DNA ligase
Mammalian ligases
Thermostable ligases
Market size by End User
Academic & Research Institutes
Hospitals & Diagnostic Centers
Pharmaceutical & Biotechnology Companies
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Ligases Enzymes market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Ligases Enzymes market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ligases Enzymes companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Ligases Enzymes submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Ligases Enzymes are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ligases Enzymes market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.